Literature DB >> 24418231

Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry.

Karl B Scheidweiler1, Marilyn A Huestis2.   

Abstract

Clandestine laboratories constantly produce new synthetic cannabinoids to circumvent legislative efforts, complicating toxicological analysis. No extensive synthetic cannabinoid quantitative urinary methods are reported in the literature. We developed and validated a liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for simultaneously quantifying JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-250, JWH-398, RCS-4, AM-2201, MAM-2201, UR-144, CP 47,497-C7, CP 47,497-C8 and their metabolites, and JWH-203, AM-694, RCS-8, XLR-11 and HU-210 parent compounds in urine. Non-chromatographically resolved alkyl hydroxy metabolite isomers were considered semi-quantitative. β-Glucuronidase hydrolyzed urine was extracted with 1ml Biotage SLE+ columns. Specimens were reconstituted in 150μL mobile phase consisting of 50% A (0.01% formic acid in water) and 50% B (0.01% formic acid in 50:50 methanol:acetonitrile). 4 and 25μL injections were performed to acquire data in positive and negative ionization modes, respectively. The LC-MS/MS instrument consisted of a Shimadzu UFLCxr system and an ABSciex 5500 Qtrap mass spectrometer with an electrospray source. Gradient chromatographic separation was achieved utilizing a Restek Ultra Biphenyl column with a 0.5ml/min flow rate and an overall run time of 19.5 and 11.4min for positive and negative mode methods, respectively. Quantification was by multiple reaction monitoring with CP 47,497 compounds and HU-210 ionized via negative polarity; all other analytes were acquired in positive mode. Lower and upper limits of linearity were 0.1-1.0 and 50-100μg/l (r(2)>0.994). Validation parameters were evaluated at three concentrations spanning linear dynamic ranges. Inter-day analytical recovery (bias) and imprecision (N=20) were 88.3-112.2% and 4.3-13.5% coefficient of variation, respectively. Extraction efficiencies and matrix effect (N=10) were 44-110 and -73 to 52%, respectively. We present a novel LC-MS/MS method for simultaneously quantifying 20 synthetic cannabinoids and 21 metabolites, and semi-quantifying 12 alkyl hydroxy metabolites in urine. Published by Elsevier B.V.

Entities:  

Keywords:  Analytical method; LC–MS/MS; Metabolites; Synthetic cannabinoids; Urine

Mesh:

Substances:

Year:  2013        PMID: 24418231      PMCID: PMC3963402          DOI: 10.1016/j.chroma.2013.12.067

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  18 in total

1.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

2.  Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-07-06       Impact factor: 3.786

3.  Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept.

Authors:  Dirk K Wissenbach; Markus R Meyer; Daniela Remane; Anika A Philipp; Armin A Weber; Hans H Maurer
Journal:  Anal Bioanal Chem       Date:  2011-05-01       Impact factor: 4.142

4.  Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.

Authors:  Simon Beuck; Ines Möller; Andreas Thomas; Annika Klose; Nils Schlörer; Wilhelm Schänzer; Mario Thevis
Journal:  Anal Bioanal Chem       Date:  2011-04-01       Impact factor: 4.142

5.  Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

Authors:  Krishna C Chimalakonda; Cindy L Moran; Paul D Kennedy; Gregory W Endres; Adam Uzieblo; Paul J Dobrowolski; E Kim Fifer; Jeff Lapoint; Lewis S Nelson; Robert S Hoffman; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-07-27       Impact factor: 6.986

6.  Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.

Authors: 
Journal:  Fed Regist       Date:  2013-05-16

7.  Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.

Authors:  Amy C Young; Evan Schwarz; Genevieve Medina; Adebisi Obafemi; Sing-Yi Feng; Colin Kane; Kurt Kleinschmidt
Journal:  Am J Emerg Med       Date:  2011-07-29       Impact factor: 2.469

8.  Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites.

Authors:  Mahmoud A ElSohly; Waseem Gul; Kareem M Elsohly; Timothy P Murphy; Vamsi L M Madgula; Shabana I Khan
Journal:  J Anal Toxicol       Date:  2011-09       Impact factor: 3.367

9.  Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.

Authors:  Cindy L Moran; Vi-Huyen Le; Krishna C Chimalakonda; Amy L Smedley; Felisia D Lackey; Suzanne N Owen; Paul D Kennedy; Gregory W Endres; Fred L Ciske; James B Kramer; Andrei M Kornilov; L D Bratton; Paul J Dobrowolski; William D Wessinger; William E Fantegrossi; Paul L Prather; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-05-06       Impact factor: 6.986

10.  LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine--an Australian perspective.

Authors:  Andrew D de Jager; Janet V Warner; Michael Henman; Wendy Ferguson; Ashley Hall
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-04-09       Impact factor: 3.205

View more
  14 in total

1.  Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability.

Authors:  Qiang Ma; Hua Bai; Wentao Li; Chao Wang; R Graham Cooks; Zheng Ouyang
Journal:  Talanta       Date:  2015-04-24       Impact factor: 6.057

2.  Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.

Authors:  Vincent Blandino; Jillian Wetzel; Jiyoung Kim; Petrit Haxhi; Richard Curtis; Marta Concheiro
Journal:  Curr Pharm Biotechnol       Date:  2017       Impact factor: 2.837

3.  Detection of synthetic cannabinoids using GC-EI-MS, positive GC-CI-MS, and negative GC-CI-MS.

Authors:  Rimako Umebachi; Takeshi Saito; Hiromichi Aoki; Akira Namera; Akihiro Nakamoto; Maho Kawamura; Sadaki Inokuchi
Journal:  Int J Legal Med       Date:  2016-08-20       Impact factor: 2.686

4.  Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.

Authors:  Marisol S Castaneto; Karl B Scheidweiler; Adarsh Gandhi; Ariane Wohlfarth; Kevin L Klette; Thomas M Martin; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-09-17       Impact factor: 3.345

5.  Validation of an ELISA Synthetic Cannabinoids Urine Assay.

Authors:  Allan J Barnes; Eliani Spinelli; Sheena Young; Thomas M Martin; Kevin L Kleete; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2015-10       Impact factor: 3.681

6.  Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Jeremy Carlier; Karl B Scheidweiler; Ariane Wohlfarth; Bonita D Salmeron; Michael H Baumann; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-06       Impact factor: 4.759

7.  Substance Abuse Profiles of Patients Admitted to the Alcohol and Drug Addiction Research, Treatment, and Education Center in Turkey.

Authors:  Fadime Canbolat; Aykut Kul; Murat Özdemir; Uğur Atik; Ahmet Aydin; S Tuncel Özden; K Nevzat Tarhan
Journal:  Turk J Pharm Sci       Date:  2017-11-20

8.  Dispersive liquid-liquid microextraction, an effective tool for the determination of synthetic cannabinoids in oral fluid by liquid chromatography-tandem mass spectrometry.

Authors:  Pierpaolo Tomai; Alessandra Gentili; Roberta Curini; Rossella Gottardo; Salvatore Fanali
Journal:  J Pharm Anal       Date:  2020-11-19

9.  Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.

Authors:  Akira Namera; Maho Kawamura; Akihiro Nakamoto; Takeshi Saito; Masataka Nagao
Journal:  Forensic Toxicol       Date:  2015-03-06       Impact factor: 4.096

Review 10.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.